Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer.
Wang X, Liu Y, Meng Z, Wu Y, Wang S, Jin G, Qin Y, Wang F, Wang J, Zhou H, Su X, Fu X, Wang X, Shi X, Wen Z, Jia X, Qin Q, Gao Y, Guo W, Lu S.
Wang X, et al.
Ann Transl Med. 2021 Apr;9(8):635. doi: 10.21037/atm-20-7155.
Ann Transl Med. 2021.
PMID: 33987333
Free PMC article.